Reference:
- Mayer KH, Agwu A, Malebranche D. Barriers to the wider use of pre-exposure prophylaxis in the United States: a narrative review. Adv Ther. 2020;37(5):1778-1811. doi:10.1007/s12325-020-01295-0
This site is an online medical resource that provides access to scientific information about Gilead products and related information. The information provided is not intended to be and should not be understood to provide medical advice.
By clicking “I’m a US healthcare professional”, you’re acknowledging that you’re a healthcare professional practicing in the US. This site is an educational resource for US healthcare professionals and may include products or uses that have not been approved by the US Food and Drug Administration.
Barriers including limited awareness, stigma, and adherence issues may prevent individuals from starting or staying on PrEP. Addressing these obstacles may help expand PrEP use and impact.1
Help expand education about PrEP to ensure individuals who may need or want PrEP are aware of it and able to obtain it.
Learn about how providers play a key role in creating a safe, affirming environment that helps normalize PrEP as a routine part of preventive health.
Explore how to help individuals maintain consistent PrEP use to reduce the likelihood of acquiring HIV through sex.
Reference: